C-Rel polyclonal antibody
Product Specifications
Background
C-Rel contains an amino-terminal DNA-binding domain referred to as the REL homology domain (REH) and carboxy-terminal transactivation domains. The c-Rel protein is typically inhibited in unstimulated cells by IκBα and IκBβ. c-Rel expression is highest in hematopoietic cells with extensive research studies demonstrating its role in immune cell function and pathogenesis of disease.
CAS Number
9007-83-4
Structure Composition
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Product Name Alternative
REL
Swiss Prot
Q04864
Reactivity
Human
Immunogen
A synthesized peptide derived from human c-Rel
Conjugation
Unconjugated
Applications
WB, IP
Dilution
WB: 1/500-1/1000 IP: 1/20
Purity
Affinity Purified
Modification
Unmodified
Molecular Weight
Calculated MW: 69 kDa; Observed MW: 69 kDa
Storage Conditions
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Notes
For research use only, not for use in diagnostic procedure.
Specificity
IgG
Applications Notes
Western blot analysis of c-Rel in Daudi lysates using c-Rel antibody.
Host or Source
Rabbit
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0046521-03 100 µg
Recombinant Bisphosphoglycerate Mutase (BPGM)
Sign In for Pricing
View Details TRV-0046521-04 200 µg
Recombinant Bisphosphoglycerate Mutase (BPGM)
Sign In for Pricing
View Details TRV-0046521-05 500 µg
Recombinant Bisphosphoglycerate Mutase (BPGM)
Sign In for Pricing
View Details